期刊文献+

人端粒酶逆转录酶与p53蛋白在甲状腺癌组织中的表达、相关性及临床意义 被引量:2

The expression,correction and clinical significance of hTERTmRNA and p53 protein in thyroid carcinoma
下载PDF
导出
摘要 目的探讨人端粒酶逆转录酶(hTERTmRNA)与突变型p53蛋白在甲状腺癌和甲状腺良性组织中的表达、相关性及临床意义。方法采用原位杂交法检测hTERTmRNA的表达,采用免疫组织化学法检测突变型p53蛋白的表达。结果①hTERTmRNA和突变型p53蛋白在甲状腺癌中高表达(P<0.05)。②hTERTmRNA与p53蛋白阳性率与甲状腺癌的临床病理分型,有无淋巴结转移,肿瘤TNM分期有关(P<0.05),与患者年龄,性别无关。③hTERTmRNA与p53蛋白在甲状腺癌组织中的表达呈显著正相关,具有统计学意义(P<0.05)。结论①hTERTmRNA和突变型p53蛋白的高表达在甲状腺癌的发生发展过程中起到重要作用。②p53蛋白调控hTERTmRNA的表达,p53蛋白在甲状腺癌中表达的增高可激活hTERTm-RNA,从而导致甲状腺癌的发生。③hTERTmRNA和p53蛋白在甲状腺癌中表达的变化可用于评估其生物学行为和判断预后,对临床上甲状腺癌的靶向治疗起到重要的指导作用。 Objective To explore the expression,correction and clinical significance of hTERTmRNA and p53 protein in thyroid carcinoma.Methods The expression of hTERTmRNA was detected by in situ hybridization,and the expression of mutant p53 protein was detected by immunohistochemistry.Results ① Overexpression of hTERTmRNA and mutant p53 protein were indicated in thyroid carcinoma tissue(P0.05).② The positive-staining rate of hTERTmRNA and mutant p53 protein were related to the different pathology classification,tumor stages,positive or negative metastasis lymph nodes(P0.05).It was not related to the age and sex of patients(P0.05).③ It demonstrated a significantly positive correlation between the expression of hTERTmRNA and mutant p53 protein in thyroid carcinoma,showing statistical significance(P0.05).Conclusion ① Overexpressed hTERTmRNA and mutant p53 protein may play an important role in the carcinogenesis and progression of thyroid carcinoma.② Mutant p53 protein regulate and control the expression of hTERTmRNA.The expression rising of mutant p53 protein in thyroid carcinoma may activate the expression of hTERTmRNA,resulting in the occurrence of thyroid carcinoma.③ Examination of expression of hTERTmRNA and mutant p53 protein may be helpful in judging the biological behavior and prognosis of thyroid carcinoma.It will perform an important directive function on the gene target therapy of thyroid carcinoma in clinical study.
出处 《实用临床医药杂志》 CAS 2011年第11期15-18,共4页 Journal of Clinical Medicine in Practice
关键词 人端粒酶逆转录酶(hTERTmRNA) 突变型p53蛋白(mtp53) 甲状腺癌(TC) 原位杂交法(ISH) 免疫组织化学法(IHC) human telomerase reverse transcriptase mutant p53 protein thyroid carcinoma in situ hybridization immunohistochemistry
  • 相关文献

参考文献7

  • 1Bowen A R, Hanks A N, Murphy K J, et al. Proliferation,apoptosis, and survivin expression in keratinocytic neoplasmsand hyperplasias [J ]. Am J Dematopathol, 2004, 26 (3) :177.
  • 2Wang L, Sofia J C, Kemp It L, et al hTERT expression is a prognostic factor of survival in patients with stage 1 non small cell lung cancer[J]. Clin Cancer Res, 2002, 8(9): 2883.
  • 3Gertler R, Rosenbern R, Stricker D, et al, Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue arid nontumorous mucosa from patients with colorectal carcinorlm[J]. Cancer, 2002, 95(10) : 2103.
  • 4马剐 高劲松 仝明 等.支气管肺泡灌洗液脱落细胞端粒酶hTERT基因发达的检测.癌症,:533-533.
  • 5施益民 鲁常青 陈同钰 等.脑转移肿瘤中mtp53、二磷酸核忤酸激酶/run23-H1的表达和临眯息义.中华试验外科杂志,2007,:322-322.
  • 6Bargonetti J, Manfredi J J. Multiple roles of the tumor sup pressor p53[J]. Curr Opin Oneol, 2002, 14(1): 86.
  • 7周卫平,王惠民,贾春平.p53基因突变的检测方法及临床应用[J].临床检验杂志,2008,26(3):224-226. 被引量:3

二级参考文献19

  • 1吴小末,朱江燕,王均永,钱玮,施慧莉,霍克克.FASAY技术在肝癌p53基因功能突变检测中的应用[J].复旦学报(自然科学版),2006,45(6):804-810. 被引量:3
  • 2方能虎,蔺丽,任吉存,吴旦.变性高效液相色谱——一种新的基因突变检测方法[J].化学进展,2005,17(2):343-349. 被引量:8
  • 3Michael K, Ahmed A A, Dariush E G, et al. High resolution mehing for mutation scanning of TP53 exon 5-8 [ J]. BMC Cancer,2007,168 (7) :1471-1484.
  • 4Ramsay G. DNA chip : state of the art[ J ]. Nat Biotechnol, 1998,16 ( 1 ) :40-44.
  • 5Meredith T, Shiva K, Matthew B,et al. p53 Mutation analysis in breast tumors by a DNA microarray method [ J ]. Cancer Epidemiol Biomarkers Prey ,2006,15 ( 1 ) :80-85.
  • 6Grollman A P,Shibutani S,Moriya M,et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy[ J]. Proc Natl Acad Sci U S A[ J]. 2007,104(29) :12129-34.
  • 7Li J H, Lax S A, Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carainomal[ J]. Int J Radiat Oncol Biol Phys, 1999,43 (3) :607-616.
  • 8Hitoshi T, Chinami S, Shoichiro T, et al. A prospective study of the significance of the gene and chromosome alteration as prognostic indicators of breast cancer patients with lymphnode metastases[ J]. Breast cancer Res Treat, 1998,48( 1 ) :21-32.
  • 9Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer [ J ]. Biochen Biophys Res Commun, 2005,331 (3) :868-880.
  • 10Eliyahu D, Dmichalovitz D, Eliyahu S,et al. Wild-type p53 can inhibit oncogene-mediated focus formation [ J ]. Proc Natl Acad Sci USA, 1989,86(22 ) :8763-8767.

共引文献2

同被引文献25

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部